Biopharmaceuticals
FDA
News Release - February 22, 2008
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Source: Abbott
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.